Hearing sensitivity in perinatally HIV-infected children by Peter Torre et al.
POSTER PRESENTATION Open Access
Hearing sensitivity in perinatally HIV-infected
children
Peter Torre III*, Alyssa Cook, Hannah Martin, Haley Elliott, Gouwa Dawood, Barbara Laughton
From International Symposium HIV and Emerging Infectious Diseases 2014
Marseille, France. 21-23 May 2013
Introduction
Research on the effects of perinatal human immunodefi-
ciency virus (HIV) exposure on hearing sensitivity is
increasing. This is important because hearing loss can
delay language and communication development in young
children. The purpose of this project was to evaluate hear-
ing sensitivity characteristics in HIV+ and HIV- children.
Materials and methods
Children were recruited from outpatient clinics within
Tygerberg Children’s Hospital in Cape Town, South Africa.
Caregiver report of middle ear infections was obtained
through a questionnaire. Bilateral otoscopy, tympanometry,
then pure-tone testing was completed. Hearing loss was
defined as a pure-tone average (PTA) of 500, 1000, 2000,
and 4000 Hz of >15 decibels of hearing level (dB HL) in the
poorer ear. Unilateral hearing loss was defined as one nor-
mal ear and one ear with hearing loss. Conductive hearing
loss was defined as an air-bone gap of ≥15 dB at a mini-
mum of two frequencies in either ear. The percentage of
children with hearing loss and mean PTA were compared
between HIV+ and HIV- children. The effect of WHO
status on hearing loss was examined for HIV+ children.
Results
Sixty-one children: 37 HIV+, 24 unexposed uninfected
(HIV-), mean age 7.1 years (SD=1.6) were assessed. HIV+
children had a higher rate of reported middle ear infections
and more conductive hearing loss. The risk for hearing loss
was higher for HIV+ children (p=0.18), who also had a sig-
nificantly higher mean PTA in the poorer ear than HIV-
children (15.1 dB vs 8.6 dB, p=0.03). Six HIV+ children
had unilateral hearing loss whereas one HIV- child had a
unilateral hearing loss. Risk for hearing loss was higher for
HIV+ children with WHO stage IV disease compared to
other stages, but not significant.
Conclusions
There were more middle ear infections, a higher risk of
hearing loss, and more unilateral hearing loss in HIV+
than HIV- children; HIV+ children had a significantly
higher PTA (worse hearing) in their poorer ear. The risk
of hearing loss was higher in those with WHO stage IV
disease than those with stage II or III.
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